Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2023-03-24 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
独立董事候选人声明（张宪胜）
Board/Management Information Classification · 90% confidence The document is a declaration statement by an independent director candidate, detailing qualifications, independence criteria, and compliance with regulatory requirements. It is a formal statement related to board membership but does not announce a change in board composition or senior management. It is not a full report, financial statement, or regulatory filing about financial results or corporate actions. It is a declaration related to board/management information but specifically about candidacy and qualifications rather than appointment or resignation. Given the content, the best fitting category is Board/Management Information (MANG), as it relates to board member candidacy and governance matters.
2023-03-24 Chinese
独立董事候选人声明（曹永长）
Board/Management Information Classification · 95% confidence The document is a declaration statement by an independent director candidate, detailing qualifications, independence criteria, and compliance with regulatory requirements. It is a formal statement related to board membership but does not announce a change in board composition or senior management. It is not a report, financial statement, or regulatory filing about financial results or corporate actions. The content fits best under Board/Management Information (MANG) as it pertains to board candidate qualifications and declarations.
2023-03-24 Chinese
华泰联合证券有限责任公司关于普莱柯生物工程股份有限公司2021年非公开发行限售股解禁上市流通的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed verification opinion from Huatai United Securities regarding the unlocking and circulation of restricted shares from a 2021 non-public issuance by Pulike Bioengineering Co., Ltd. It includes specifics about the share issuance, lock-up periods, shareholder commitments, shareholding changes, and compliance with regulatory requirements. The document is not a financial report, earnings release, or management discussion but rather a regulatory compliance and verification statement related to share issuance and circulation. This fits best under the category of Capital/Financing Update (CAP), as it deals with share issuance, lock-up expiration, and share circulation updates. The document length is 3140 characters, which is consistent with a detailed announcement rather than a full report. Therefore, the classification is CAP with high confidence.
2023-03-13 Chinese
普莱柯关于2021年非公开发行限售股解禁上市流通的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the lifting of restrictions on non-publicly issued restricted shares and their listing for circulation. It details the number of shares becoming tradable, the dates, the shareholders involved, and the compliance with regulatory requirements. It does not contain financial statements or performance data but focuses on share capital changes and regulatory compliance related to share circulation. This fits the category of Share Issue/Capital Change announcements rather than a full financial report or other types of filings.
2023-03-13 Chinese
普莱柯关于董事会、监事会延迟换届的公告
Board/Management Information Classification · 100% confidence The document is an announcement from a company about the delay in the re-election of its board of directors and supervisory board. It discusses the extension of the current board's term and the continuation of duties until the new board is elected. There is no financial data, no mention of annual or interim reports, no voting results, and no mention of any other report types. This is clearly an announcement related to board/management information, specifically about changes or delays in board composition. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short and it is not a report publication or certification, so it does not fall under RPA or RNS.
2023-02-28 Chinese
普莱柯股东集中竞价减持股份结果公告
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement regarding the results of a shareholder's reduction in holdings through centralized bidding. It details the shareholder's name, shareholding percentages before and after the reduction, the number of shares reduced, the time period of the reduction, and references to previous announcements about shareholding changes. There is no financial statement, earnings data, or management discussion. The content focuses on the shareholder's transaction in their own shares, specifically a reduction in holdings. This fits the definition of 'Transaction in Own Shares' (POS) filings, which report company directors or major shareholders buying back or selling their own shares. The document length is short (1621 characters), and it is not an announcement of a report publication but a direct disclosure of share transactions.
2023-01-29 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.